Jong Un Cho

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Legochem Biosciences, Inc., Intocell, Inc., Legochem Bioscience Ltd.. Active years: 2014-2026.

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 11.3

ph-index = 4

Forward Citations = 66(Granted Patents)

Company Filing History:

4 out of 25

Legochem Biosciences, Inc.

Legochem Bioscience Ltd.

Years Active: 2014-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576156 - Compound comprising self-immolative group and ligand-drug conjugate comprising same (2026-03-17),

2. 11065343 - Compound bearing beta-galactoside-introduced self-immolative linker (2021-07-20),

3. 10980890 - Compounds comprising self-immolative group (2021-04-20),

4. 10383949 - Compounds comprising self-immolative group (2019-08-20),

5. 9993568 - Compounds comprising self-immolative group (2018-06-12),

6. 9919057 - Compounds comprising self-immolative group (2018-03-20),

7. 8637667 - Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives (2014-01-28),

Title: Jong Un Cho: Innovator in Self-Immolative Linkers

Introduction

Jong Un Cho is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of self-immolative linkers. With a total of 7 patents to his name, Cho's work is recognized for its innovative approach to targeted drug delivery.

Latest Patents

One of Cho's latest patents is titled "Compound bearing beta-galactoside-introduced self-immolative linker." This invention relates to a compound that features a self-immolative linker with a β-galactoside component. The self-immolative linker can form a glycosidic bond with proteins or ligands that have a specific affinity for desired targets. This allows for the selective release of active agents within target cells, enhancing the efficacy of therapeutic applications. Another significant patent involves "Compounds comprising self-immolative group," which includes compounds that may consist of proteins with substrate-specificity for targets and active agents with specific functions.

Career Highlights

Throughout his career, Jong Un Cho has worked with various companies, including Legochem Biosciences, Inc. and Intocell, Inc. His experience in these organizations has contributed to his expertise in the development of innovative biochemical solutions.

Collaborations

Cho has collaborated with notable coworkers such as Sung Ho Woo and Tae Kyo Park. Their combined efforts have further advanced the research and development of self-immolative linkers and related compounds.

Conclusion

Jong Un Cho is a prominent figure in the field of biochemistry, with a focus on self-immolative linkers that have the potential to revolutionize targeted drug delivery. His innovative patents and collaborations highlight his significant contributions to the scientific community.